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Abstract
Identifying regions of the genome that are depleted of mutations can reveal potentially deleterious 
variants. Short tandem repeats (STRs), also known as microsatellites, are among the largest 
contributors of de novo mutations in humans. However, per-locus studies of STR mutations have 
been limited to highly ascertained panels of several dozen loci. Here, we harnessed bioinformatics 
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tools and a novel analytical framework to estimate mutation parameters for each STR in the 
human genome by correlating STR genotypes with local sequence heterozygosity. We applied our 
method to obtain robust estimates of the impact of local sequence features on mutation parameters 
and used this to create a framework for measuring constraint at STRs by comparing observed vs. 
expected mutation rates. Constraint scores identified known pathogenic variants with early onset 
effects. Our metric will provide a valuable tool for prioritizing pathogenic STRs in medical 
genetics studies.
Introduction
Mutations that have negative fitness consequences tend to be eliminated from the population. 
Thus, identifying regions of the genome that are depleted of mutations has proven a useful 
strategy for interpreting the significance of de novo variation in developmental disorders1, 
prioritizing rare disease variants2, and identifying genes or non-coding regions of the 
genome that are under selective constraint3,4. The key idea of these approaches is that 
mutations occurring at sites evolving under a neutral model are likely to have little effect on 
reproductive fitness, whereas mutations at intolerant sites are more likely to be involved in 
severe early-onset disorders.
So far, the genetics community has developed a multitude of methods to assess genetic 
constraint. These studies have highlighted the importance of a carefully calibrated model of 
the background mutation process to establish a neutral expectation. For instance, Samocha et 
al.1 determine the expected number of de novo variants per gene based on a neutral model 
obtained by counting mutations for each possible trinucleotide context in intergenic SNPs. 
In a different approach, fitCons3 aggregates non-coding regions with similar functional 
annotations and compares observed variation in those regions to an expectation obtained 
from presumably neutral flanking regions. Notably, these methods have mainly focused on 
single nucleotide polymorphisms (SNPs) and to a lesser extent on small indels. As of today, 
computational methods to analyze and assess the functional impact of repetitive elements in 
the genome are lacking. Thus, repeat variants are commonly excluded from medical genetics 
analyses.
To expand the range of interpretation tools to repeat elements, we focused on short tandem 
repeats (STRs), also known as microsatellites, in the human genome. STRs consist of 
repeated motifs of 1–6bp and represent about 1.6 million loci5, rendering them one of the 
largest repeat classes. STR mutations are responsible for over 30 Mendelian disorders6, 
many of which are thought to arise spontaneously from de novo mutations7,8. Emerging 
evidence suggests STRs play an important role in complex traits9 such as gene expression10 
and DNA methylation11. In addition, analyses of cancer cell lines have shown that STR 
instability is a chief clinical sign for tumor prognosis12, but the functional impact of these 
instabilities is largely unknown.
Evaluating genetic constraint requires two fundamental components: an accurate mutation 
model and a deep catalog of existing variation. Both of these have been difficult to obtain for 
repetitive regions of the genome. Current knowledge of the STR mutation process is based 
on low-throughput studies focusing on an ascertained panel of loci that are highly 
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polymorphic. These include genealogical STRs on the Y chromosome13,14, approximately a 
dozen autosomal STRs from the CODIS (Combined DNA Index System) set used in 
forensics, and several thousand STRs historically used for linkage analysis15. These studies 
suggest an average mutation rate of approximately 10−3 to 10−4 mutations per 
generation13–17. However, these loci likely have significantly higher mutation rates than 
most STRs. Moreover, well characterized STRs consist almost entirely of tetra- or di-
nucleotide repeats, which may mutate with different rates and processes compared to other 
repeat classes. Finally, STR mutation rate studies have been based on small numbers of 
families and show substantial differences regarding absolute mutation rates and their 
patterns (Supplementary Table 1).
Here, we developed a framework to measure constraint at individual STRs that benefits from 
a novel method to obtain observed and expected mutation rates at each locus. We developed 
a robust quantitative model that harnesses population-scale genomic data to estimate locus-
specific mutation dynamics at each STR by correlating local SNP heterozygosity with STR 
variation. After extensive validation, we applied this model to estimate mutation rates at 
more than one million STRs using whole genome sequencing of 300 unrelated samples from 
diverse populations18. Using these results, we built a model to predict mutation parameters 
from local sequence features and measured constraint at each STR locus. One caveat is that 
our method is primarily applicable to STRs that can be completely spanned by short reads 
and does not accurately describe large expansion mutations observed in conditions such as 
Huntington’s Disease or Fragile X Syndrome. We show that our constraint metric can be 
used to predict clinical relevance of individual STRs, including those in genes with known 
implications in developmental disorders. This framework will likely enable better 
assessment of the role of STRs in human traits and will inform future work incorporating 
STRs into human genetics studies.
Results
A method to estimate local mutation parameters
We first sought to develop a method to estimate mutation parameters at each STR in the 
genome by fitting a model of STR evolution to population-scale data. A primary 
requirement of our method is a model of the STR mutation process that fits observed 
variation patterns. Motivated by the poor fit of the widely used generalized stepwise 
mutation model (GSM) to our data (Supplementary Note), we developed a novel length-
biased version of the GSM that closely recapitulates observed population-wide trends 
(Supplementary Note, Supplementary Figures 1,2), including a saturation of the STR 
molecular clock over time. Our model includes three parameters: μ denotes the per-
generation mutation rate, β describes the strength of the directional bias of mutation, and p 
paramaterizes the geometric mutation step size distribution. Recently, we developed a 
method called MUTEA that employs a similar model to precisely estimate individual 
mutation rates for Y chromosome STRs (Y-STRs) from population-scale sequencing of 
unrelated individuals. MUTEA models STR evolution on the underlying SNP-based Y 
phylogeny19. We found good concordance (r2=0.87) between MUTEA and traditional trio-
based methods and high reproducibility (r2=0.92) across independent datasets. However, the 
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main limitation of this approach is that it requires full knowledge of the underlying 
haplotype genealogy, which is difficult to obtain for autosomal loci.
To analyze the mutation rates of autosomal STRs, we extended MUTEA to analyze pairs of 
haplotypes. The key insight of our mutation rate estimation procedure is that different 
classes of mutations provide orthogonal molecular clocks (Figure 1). Consider a pair of 
haplotypes consisting of an STR and its surrounding sequence. The SNP heterozygosity is a 
function of the time to the most recent common ancestor (TMRCA) of the haplotypes and 
the SNP mutation rate. On the other hand, the squared difference between the numbers of 
repeats of the two STR alleles (allele squared distance, or ASD) is a separate function of the 
TMRCA. The distribution of ASD values observed for a given TMRCA is determined by 
our STR mutation model. Using known parameters of the SNP mutation process, we can 
estimate the local TMRCA and calibrate the STR molecular clock15.
Our method takes as input unphased STR and SNP genotypes and returns maximum 
likelihood estimates of STR mutation parameters. The TMRCA is approximated by local 
SNP heterozygosity using a pairwise sequentially Markovian coalescent model20 
(Methods). ASD is calculated directly from a diploid STR genotype as the squared 
difference in the number of repeats of each allele. Our maximum likelihood framework 
allows us to estimate parameters at a single STR or jointly across many loci. A potential 
caveat is that haplotype pairs may have shared evolutionary history and thus are not 
statistically independent, which is not expected to bias our estimates but will artificially 
shrink standard errors. To account for this non-independence, we adjust standard errors by 
calibrating to ground truth simulated and capillary electrophoresis datasets (Supplementary 
Note, Supplementary Figure 3).
Validating parameter estimates
We first evaluated our estimation procedure on STR and SNP genotypes simulated on 
haplotype trees using a wide range of mutation parameters. To evaluate our method on 
unphased diploid data, we formed a set of 300 “diploids” by randomly selecting leaf pairs 
and recording the TMRCA and STR allele lengths. To test the effects of genotyping errors, 
we simulated “stutter” errors using the model described in Willems et al.19 and used the 
expectation-maximization framework we developed previously21 to estimate per-locus 
stutter noise and correct for STR genotyping errors.
Our method obtained accurate per-locus estimates for μ for most biologically relevant 
parameter ranges (Figure 2a). Notably, estimates for p and β were less precise 
(Supplementary Figure 4) and thus downstream analyses focused on mutation rates. The 
main limitation of our method is an inability to capture low mutation rates. Informative 
estimates could be obtained for rates >10−6. This presumably stems from the low number of 
total mutations observed (median 1 mutation for μ = 10−6 in 300 samples). Aggregating loci 
or analyzing larger sample sizes gives higher power to estimate low mutation rates due to the 
higher number of total mutations observed. By analyzing loci jointly, we could accurately 
estimate mutation rates down to 10−6 with 30 or more loci and 10−7 with 70 or more loci 
(Figure 2b). As expected, inferring and modeling stutter errors correctly removed biases 
induced by stutter errors (Supplementary Figure 5).
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We next evaluated the ability of our method to obtain mutation rates from population-scale 
sequencing of Y-STRs whose mutation rates have been previously characterized. We 
analyzed 143 males sequenced to 30–50x by the Simons Genome Diversity Project18 
(SGDP) and 1,243 males sequenced to 4–6x by the 1000 Genomes Project22. We used all 
pairs of haploid Y chromosomes as input to our maximum likelihood framework. We 
compared our results to two orthogonal mutation rate estimates: our previous MUTEA 
method19 and a study that examined 2,000 father-son duos13. We found that our mutation 
rate estimates were consistent across sequencing datasets (r=0.90; two-tailed p=1.5×10−18; 
n=48) (Supplementary Figure 6). Encouragingly, our rate estimates were similar to those 
reported by MUTEA on the SGDP dataset (r=0.89; two-tailed p=5.9×10−15; n=41) (Figure 
2c). Furthermore, our estimates were significantly correlated with those reported by 
Ballantyne et al. (r=0.78; two-tailed p=2.0×10−9; n=41) (Supplementary Figure 6), a 
substantial improvement over results obtained using a traditional stepwise mutation model 
(r=0.37; two-tailed p=0.0150; n=41), validating our choice of mutation model.
Finally, we evaluated our method on a subset of well characterized autosomal diploid loci. 
We first analyzed the forensics CODIS markers, which have well-characterized mutation 
rates estimated across more than a million meiosis events (see URLs). Mutation rates were 
concordant with published CODIS rates (r=0.90; two-tailed p=0.00016; n=11) 
(Supplementary Figure 7). We also compared to di- and tetranucleotide mutation rates 
previously estimated by Sun et al. by aggregating data from 1,634 loci in 85,289 
Icelanders15. Mutation rates were in strong agreement (Figure 2d, Supplementary Figure 8), 
which is especially encouraging given that the Sun et al. STR genotypes were obtained using 
an orthogonal capillary electrophoresis method.
Genome-wide characterization of the STR mutation process
Next, we applied our mutation rate estimation method genome-wide. We analyzed 300 
individuals from diverse genetic backgrounds sequenced to 30–50x coverage by the SGDP 
Project18. We aligned reads to the hg19 reference genome using BWA-MEM23 and the 
resulting alignments were used as input to lobSTR24 (Methods). High quality SNP 
genotypes were obtained from our previous study18. We used these as input to PSMC20 to 
estimate the local TMRCA between haplotypes of each diploid individual. For each locus, 
we adjusted genotypes for stutter errors (Supplementary Figure 9, Supplementary Table 2, 
Methods) and used adjusted genotypes as input to our mutation rate estimation technique. 
After filtering (Methods), 1,251,510 STR loci with an average of 249 calls/locus remained 
for analysis. Results were concordant with mutation rates predicted by extrapolating 
MUTEA to autosomal loci (r=0.71; two-tailed p<10−16; n=480,623) (Supplementary Figure 
10), suggesting that our mutation rate estimation is robust even in the case of unphased 
genotype data from modest sample sizes.
Per-locus mutation rates for each repeat motif length varied over several orders of 
magnitude, ranging from 10−8 to 10−2 mutations per locus per generation (Supplementary 
Figure 11, Supplementary Table 3). Median mutation rates were highest for homopolymer 
loci (log10μ = −5.0) and decreased with the length of the repeat motif, with most 
pentanucleotides and hexanucleotides below our detection threshold. Interestingly, 
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homopolymers also showed markedly higher length constraint compared to other loci, 
suggesting an increased pressure to maintain specific lengths. Step size distributions also 
differed by repeat motif length. Homopolymers (median p = 1.00) and to a lesser extent 
repeats with motif lengths 3–6 (median p = 0.95) almost always mutate by a single repeat 
unit. On the other hand, dinucleotides are more likely to mutate by multiple units at once, 
consistent with previous studies15. Overall, our results highlight the diverse set of influences 
on the STR mutation process and suggest there is limited utility to citing a single set of STR 
mutation parameters.
A framework for measuring STR constraint
Encouraged by the accuracy of our per-locus autosomal parameter estimates, we sought to 
create a framework to evaluate genetic constraint at STRs by comparing observed to 
expected mutation rates. Our framework relies on generating robust predictions of per-locus 
mutation rates based on local sequence features and comparing the departure of the observed 
rates from this expectation (Figure 3a). STRs whose observed mutation rates are far lower 
than expected are assumed to be under selective constraint and thus more likely to have 
negative fitness consequences.
We began by evaluating whether local sequence features can accurately predict STR 
mutation rates. We examined the relationship between STR mutation rate and a variety of 
features, including total STR length, motif length, replication timing, and motif sequence 
(Supplementary Figure 12). While all features were correlated with mutation rate 
(Supplementary Table 4), total uninterrupted repeat sequence length and motif length were 
by far the strongest predictors, as has been previously reported by many studies15,19. These 
features were combined into a linear regression model to predict per-locus mutation rates. 
We stringently filtered the training data to consist of presumably neutral (intergenic) loci 
with the best model performance. Analysis was restricted to STRs with motif lengths of 2–
4bp with reference length ≥ 20bp and small standard errors (Methods), since this subset 
showed mutation rates primarily in the range that our model can detect. Using this filtered 
set of markers, a linear model explained 65% of variation in mutation rates in an 
independent validation set (Figure 3b).
We next developed a metric to quantify constraint at each STR by comparing observed to 
expected mutation rates. Our constraint metric is calculated as a Z-score, taking into account 
errors in both the predicted and observed values (Methods). Negative Z-scores denote loci 
that are more constrained than expected, and vice versa. Constraint scores for loci with 
detectable mutation rates followed the expected standard normal distribution 
(Supplementary Figure 13). However, loci with mutation rates below our detection threshold 
of 10−6 do not have reliable standard error estimates and had downward biased scores. 
Nevertheless, these loci are informative of a constraint signal in cases where the predicted 
mutation rate is high but the observed rate is below our detection threshold. Thus, rather than 
analyzing distributions of raw constraint scores, we binned scores by deciles and examined 
enrichments for functional annotations in each bin. For comparison, we also calculated 
mutation rates and constraint scores assuming a generalized stepwise model (Methods) and 
found that mutation rates and constraint scores were similar (r=0.88 and r=0.56 for mutation 
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rates and constraint scores, respectively). All constraint scores analyzed below were 
calculated using the length-constrained model.
STR constraint scores give insights into human phenotypes
Observed Z-scores are concordant with biological expectations across genomic features. 
Introns, intergenic, and 3′-UTR regions closely matched neutral expectation (Figure 3c). On 
the other hand, STRs in coding exons showed significantly reduced mutation rates compared 
to the null model. These trends were recapitulated in the expected mutation rates (Figure 
3d), suggesting that STRs under constraint are also under evolutionary pressure to maintain 
sequence features contributing to lower mutability. Additional analysis of STR constraint in 
coding regions is given in Supplementary Note and Supplementary Figure 14. In contrast to 
strong levels of constraint in coding exons, the STRs that we had previously identified to act 
as expression quantitative trait loci (eQTLs)10 showed a marked lack of constraint, 
consistent with observations in the Exome Aggregation Consortium (ExAC) dataset25 
showing highly constrained genes are depleted for eQTLs.
Constraint can provide a useful metric to prioritize potential pathogenic variants and 
interpret the role of individual loci in human conditions. Notably, this metric is most 
sensitive to early-onset disorders, as mutations involved in later onset disorders generally do 
not affect fitness and are thus expected to follow neutral patterns. Additionally, constraint is 
most sensitive to deleterious mutations following dominant inheritance patterns, since 
recessive mutations are eliminated at much slower rates. Consistent with this theory, STRs 
implicated in early onset dominant diseases show significantly higher constraint than 
expected (Figure 4). We focused on STRs that can be genotyped from high throughput 
sequencing data and are involved in congenital disorders. Notably, this excludes most large 
repeat expansions such as those involved in Huntington’s Disease or Fragile X Syndrome. 
First, we examined polyalanine and polyglutamine tracts in RUNX2. Even mild expansion 
of four glutamine residues has been shown to result in congenital cleidocranial dysplasia 
(OMIM: 119600)26,27. Both repeats showed constrained mutation rates, with the 
polyglutamine repeat in the most constrained bin (Z=−11.3). Next, we tested a polyalanine 
expansion in HOXD13, which causes a severe form of synpolydactyly (OMIM: 186000). 
Again, a mild expansion (7 additional residues) has been shown to be pathogenic28. This 
repeat was on the boundary of the most severe constraint bin (Z=−10.9). As a negative 
control, we also tested constraint at the CODIS loci used in forensics, which have been 
specifically ascertained for their high polymorphism rates and are likely neutral. As 
expected, the CODIS markers have weak constraint scores, and exhibit slightly higher 
mutation rates than expected (Z>0) (Figure 4).
More broadly, we found protein-coding STRs are highly enriched in genes that are involved 
in developmental processes (Fisher’s exact test p=1.88×10−36; nfg=1,133; nbg=20,913). 
Consistent with this result, three of the ten most highly constrained coding STRs in our 
dataset are in genes with previously reported developmental disorders following autosomal 
dominant inheritance patterns that have yet to be associated with pathogenic STRs: GATA6 
(congenital heart defects, OMIM: 600001), SOX11 (mental retardation, OMIM: 615866), 
and BCL11B (Immunodeficiency 49, OMIM: 617237) (Supplementary Table 5). On the 
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other hand, we found that pathogenic STRs of late onset STR expansions disorders such as 
spinocerebellar ataxias were not highly constrained and showed mutation rates very close to 
predicted values (Figure 4). These disorders often do not occur until the fourth or fifth 
decade of life29, and thus are not expected to be under strong purifying selection. Taken 
together, these results suggest STR constraint scores will provide a useful metric by which to 
prioritize rare pathogenic variants involved in severe developmental disorders.
To facilitate use by the genomics community, genome-wide results of our mutational 
constraint analysis are provided in BED format (see Data Availability), which can be 
analyzed with standard genomics tools such as BEDtools30.
Discussion
Metrics for quantifying genetic constraint by comparing observed to expected variation have 
provided a valuable lens to interpret the impact of de novo SNP variants. These have been 
widely used for applications including quantifying the burden of de novo variation in 
neurodevelopmental disorders1,31, identifying individual genes constrained for missense or 
loss of function variation25, and more recently to measure constraint in non-coding 
elements4,32. However, the mutation rate at SNPs is sufficiently low that any given 
nucleotide has a low probability of being covered by a polymorphism even in very large 
datasets of human variation (e.g. a dataset of more than 60,000 exomes contained about 1 
polymorphism per 8 nucleotides25). Thus, the information provided by SNP variation is 
never sufficient to provide a direct measurement of the likely evolutionary constraint on a 
particular mutation. In contrast, the much higher mutation rate at STRs makes it possible to 
precisely measure constraint on a per-locus basis even with as few as 300 whole genomes.
We combined a deep catalog of STR variation18 with a novel model of the STR mutation 
process to develop an accurate method for measuring per-locus STR mutation parameters. 
We used this method to estimate individual mutation rates for more than 1 million STRs in 
the genome. Observed STR mutation rates vary over several orders of magnitude, suggesting 
it is not useful to cite a single mutation rate for all STRs. Median genome-wide mutation 
rates were far lower than previously reported15–17,33. This is consistent with the fact that 
most well studied STR panels were specifically ascertained for their high heterozygosity, 
needed for traditional STR applications such as forensics or genetic linkage analysis. Our 
estimates confirm many known trends in STR mutation, such as the dependence of mutation 
rate on total STR length and the tendency of dinucleotide repeats to mutate in larger units 
than tetranucleotides15. Moreover, this large dataset allows us to exclude the possibility that 
certain sequence features such as local GC content play a strong role in determining STR 
mutation rates.
By comparing observed to expected mutation rates, we showed that we can measure genetic 
constraint at individual loci and use our constraint metric to prioritize potentially pathogenic 
variants. Importantly, our approach provides a biologically agnostic approach to assessing 
the importance of individual loci, as it relies entirely on observed genetic variation. While 
our analyses focused on STRs, the framework developed here can be easily extended to any 
class of repetitive variation for which accurate genotype panels are available. In future 
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studies, we envision this work will provide a much needed framework to interpret the dozens 
of de novo variants at STRs and other repeats arising in each individual, especially in the 
context of severe early onset disorders. Beyond analyzing de novo variation, accurate models 
of STR mutation will enable scans for STRs under selection34, help identify rapidly 
mutating markers for forensics or genetic genealogy19,35, and improve statistical methods 
for incorporating STRs into quantitative genetics studies.
Our mutation rate estimation method and constraint metric face several limitations. First, 
estimating mutation rates in several hundred samples is only accurate for mutation rates 
down to approximately 10−6. Loci with slower mutation rates produce biased results, 
limiting our ability to predict and measure mutation rates at a large number of loci, including 
the majority of protein coding STRs. While we can detect general signals of constraint for 
slowly mutating STRs, larger sample sizes will allow for more accurate constraint scores 
and thus more informative prioritization. Second, our method analyzes pairs of haplotypes 
rather than the entire evolutionary history of a locus. While this has the advantage of 
allowing estimation across unphased data, it discards valuable information present in the full 
haplotype tree and limits the scope of models that can be considered. For example, it 
precludes modeling allele length-specific mutation rates, which requires estimating ancestral 
states on the full haplotype tree. Finally, there are additional aspects of the STR mutation 
process not modeled here. Our method focuses on short stepwise mutations occurring at 
relatively stable STRs. Unstable expansions, such as those occurring in trinucleotide repeat 
disorders, likely mutate by different models. Our model also ignores the effect of sequence 
interruptions and putative interactions between alleles, both of which have been 
hypothesized to influence STR mutation patterns19,36.
Future bioinformatic advances will likely overcome many of these issues and improve the 
precision of our estimates. In particular, while our method works on unphased data, phased 
STR and SNP haplotypes would allow analysis of the entire haplotype tree at a given locus 
as is done by MUTEA, improving our accuracy and allowing us to consider a broader range 
of mutation models. Additionally, our current tools are limited to STRs that can be spanned 
by short reads, and thus exclude many well known pathogenic loci such as those involved in 
trinucleotide repeat expansion disorders. We envision that long read and synthetic long read 
technologies will both enable analysis of a broader class of repeats and provide an additional 
layer of phase information. Finally, larger sample sizes will allow more accurate analysis of 
constraint for slow-mutating loci. Taken together, these advances will provide a valuable 
framework for interpreting mutation and selection at hundreds of thousands of STRs in the 
genome and will help prioritize STR mutations in clinical studies.
Online Methods
STR mutation model
We model STR mutation using a discrete version of the Ornstein-Uhlenbeck process 
described in detail in the Supplementary Note. Our model assumes STR mutations occur at a 
rate of μ mutations per locus per generation according to a step-size distribution with first 
and second moments:
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where ai is the length of the STR allele after mutation i and ai+1 is the length after mutation i 
+1. This implies that long alleles (>0) tend to decrease back toward 0 and short alleles (<0) 
tend to increase toward 0. For all analyses, all alleles are assumed to be relative to the major 
allele, which is set to 0.
Mutation parameter estimation
We extended the MUTEA framework to estimate parameters at diploid loci for which the 
underlying haplotype tree is unknown. For each sample genotyped at locus j, we obtain tij, 
the TMRCA between the two haplotypes of sample i, and a distribution Gij, where Gij(a,b) 
gives the posterior probability that sample i has genotype (a,b). We initially assume that 
haplotype pairs are independent and maximize the following likelihood function at locus j:
Where θ = {μ, β, p}, Dj = {(G1j, t1j), (G2j, t2j)...(Gnj, tnj)}, n is the number of samples, and 
A(x|t) gives the probability of observing a squared distance of x between alleles on 
haplotypes with a TMRCA of t. We used the Nelder-Mead algorithm to minimize the 
negative of the log-likelihood and imposed boundaries of μ ∈ [10−8, 0.05], β ∈ [0,0.9], p ∈ 
[0.7, 1.0].
To compute the function A, we first build a transition matrix M of size L × L, where L is the 
number of allowed alleles. M[a,b] gives the probability that allele a mutates to allele b in a 
single generation. Step sizes were set based on the model described in Supplementary Note:
where  and .
M represents a stochastic process, and thus MT gives transition probabilities along a branch 
T generations long. A single row MT[a,:] gives the expected allele frequency spectrum of a 
locus for which the ancestral allele was a and the MRCA was T generations ago. We can use 
this to derive the probability of observing a given squared distance between two alleles 
separated by t generations:
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In our data, we do not know the ancestral allele a for each pair of haplotypes. However, 
under our model of STR evolution, A does not depend on the ancestral allele and so we 
assume 0 as the ancestral allele for simplicity. Notably, we have assumed haplotype pairs are 
statistically independent. While this does not bias our results, standard errors must be 
adjusted as described in the Supplementary Note.
Estimating mutation parameters using a generalized stepwise model
Under a generalized stepwise model (GSM), the ASD should be linearly related to the 
TMRCA between a pair of haplotypes37:
Where ai and aj are the repeat lengths of STR alleles on two haplotypes i and j, tij is the 
TMRCA between that pair of haplotypes, and μeff is the effective mutation rate. The 
effective mutation rate is defined as , where μ is the per-generation mutation rate 
of the locus and step sizes are drawn from a distribution with mean 0 and variance .
For each locus, we calculated μeff by regressing ASD on TMRCA and dividing the resulting 
slope by 2.
Joint estimation of mutation parameters across multiple loci
The MUTEA approach can be easily extended to estimate mutation parameters in aggregate 
by jointly maximizing the likelihood across multiple loci at once:
To minimize computation and because β and p tended to be less consistent across loci, we 
first perform per-locus analyses to obtain individual estimates for β and p. We then hold 
these parameters constant at the mean value across all loci and only maximize the joint 
likelihood across μ
Simulating SNP-STR haplotypes
We used fastsimcoal38 to simulate coalescent trees for 600 haplotypes using an effective 
population size of 100,000. We then forward-simulated a single STR starting with a root 
allele of 0 using specified values of μ, β, and . Mutations were generated according 
to a Poisson process with rate  and following the model described above. We chose 300 
random pairs of haplotypes to form “diploid” individuals to use as input to our estimation 
method. We simulated reads for each locus assuming 5x sequencing coverage, with each 
read equally likely to originate from each allele. Stutter errors were simulated using the 
model described in Willems et al.19 with u = 0.1, d = 0.05, and ρs = 0.9. This indicates that 
stutter noise causes the true allele to expand or contract with 10% or 5% frequency, 
respectively, and that error sizes are geometrically distributed with 10% probability of 
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mutating by more than one repeat unit. For estimating per-locus parameters, we performed 
10 simulations with each set of parameters.
Datasets
Previously published mutation rate estimates—MUTEA mutation rate and length 
bias estimates for the 1000 Genomes dataset were obtained from Table S1 in Willems et 
al.19 De novo Y-STR mutation rate estimates were obtained from Table S1 of Ballantyne et 
al.13 CODIS mutation rates were obtained from NIST (see URLs).
Annotations—Local GC content and sequence entropy were obtained from the “strinfo” 
file included in the lobSTR hg19 reference bundle. Missense constraint scores were 
downloaded from the ExAC website (see URLs).
STR genotyping
Profiling STRs from short reads—Raw sequencing reads for the SGDP dataset were 
aligned using BWA-MEM23. Alignments were used as input to the allelotype tool packaged 
with lobSTR24 version 4.0.2 with non-default flags “—filter-mapq0 –filter-clipped –max-
repeats-in-ends 3 –min-read-end-match 10 –dont-include-pl –min-het-freq 0.2 –noweb”. 
STR genotypes are available on dbVar under accession nstd128. Y-STRs for the 1000 
Genomes data were previously profiled24 and were preprocessed as described in19.
Filtering to obtain high quality STR calls—Y-STR calls for SGDP were filtered using 
the lobSTR_filter_vcf.py script available in the lobSTR download with arguments “--loc-
max-ref-length 80 --loc-call-rate 0.8 --loc-log-score 0.8 --loc-cov 3 --call-cov 3 --call-dist-
end 20 --call-log-score 0.8” and ignoring female samples. Autosomal samples were filtered 
using “--loc-max-ref-length 80 --loc-call-rate 0.8 --loc-log-score 0.8 --loc-cov 5 --call-cov 5 
--call-dist-end 20 --call-log-score 0.8”.
Calculating local TMRCA
As described in Mallick et al.18, we used the pairwise sequential Markovian coalescent 
(PSMC)20 to infer local TMRCAs across the genome in each sample. For each region 
overlapping an STR, we calculated the geometric mean of the upper and lower 
heterozygosity estimates returned by PSMC. We scaled heterozygosity to TMRCA based on 
the genome-wide average PSMC estimate (0.00057) of a French sample with a previously 
estimated genome-wide average TMRCA of 21,000 generations15. To accommodate errors 
in this scaling process, final mutation rate estimates were scaled to match the mean values of 
published de novo rates (see below).
Pairwise Y chromosome analysis
For each pair of SGDP Y-chromosomes, we first calculated the pairwise sequence 
heterozygosity. We then scaled this to TMRCA using the relationship ti = hi/2μYSNP, where 
hi is the heterozygosity of pair i and μYSNP is the Y-chromosome SNP mutation rate. μYSNP 
was set to 2.1775×10−8 as reported by Helgason et al.39 For the 1000 Genomes set, we 
obtained a Y-phylogeny that was built by the 1000Y analysis group40. We scaled the tree 
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using a method described previously19. For each dataset, we used pairwise TMRCA and 
allele squared distance estimates as input to our maximum likelihood procedure.
Scaling mutation parameters
Our TMRCA estimates, and thus mutation rate estimates, scale linearly with the choice of 
SNP mutation rate. To account for this and to compare estimates between datasets, we scaled 
our mutation rates by a constant factor such that the mean STR mutation rates between 
datasets were identical. Genome-wide estimates are scaled based on the comparison with 
CODIS rates.
Measuring STR constraint
Predicting mutation rates from local sequence features—We trained a linear 
model to predict log10 mutation rates from local sequence features including GC content, 
replication timing, sequence entropy, motif sequence, motif length, total STR length, and 
uninterrupted STR length. The model was built using presumably neutral intergenic loci, 
with 75% of the loci reserved for training and 25% for testing. While all features were 
correlated with mutation rates, the best test performance was achieved using only motif 
length and uninterrupted STR length. Models were built using the python statsmodels 
package (see URLs).
Model training was restricted to STRs whose mutation rates could be reliably estimated. We 
filtered STRs with total reference length <20bp, since the majority of shorter STRs returned 
biased mutation rates at the optimization boundary of 10−8. We further filtered STRs with 
standard errors equal to 0, >0.1, or undefined (usually indicating the lower optimization 
boundary of 10−8 was reached). However, these loci were included in testing and in 
downstream analysis as the majority of coding STRs fell into this category.
Calculating Z-scores—Constraint scores are calculated for each locus i as:
Where μi is the observed mutation rate, SE[μi] is the standard error of the observed mutation 
rate, E[μi] is the predicted mutation rate, and Var[μi] is the variance of the prediction. In all 
cases, μi refers to the log10 mutation rate, with the log10 notation omitted for simplicity.
Constraint score analysis—GO analysis was performed using goatools (see URLs). 
OMIM disease annotations were accessed on December 8, 2016.
Data availability
Per-locus mutation parameters are available at https://s3-us-west-2.amazonaws.com/
strconstraint/Gymrek_etal_SupplementalData1_v2.bed.gz. The file format is described in 
https://s3-us-west-2.amazonaws.com/strconstraint/readme_v2.txt.
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Code availability
Code used in this study is available at https://github.com/gymreklab/mutea-autosomal.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
D.R. was supported by NIH grants GM100233 and HG006399 and is a Howard Hughes Medical Institute 
investigator. M.G. was supported by NIH/NIMH grant 1U01MH105669-01. Y.E. holds a Career Award at the 
Scientific Interface from the Burroughs Wellcome Fund. This study was supported in part by National Institute of 
Justice grant 2014-DN-BX-K089 (Y.E., T.W., M.G.) and by a generous gift by Paul and Andria Heafy (Y.E.). We 
thank N. Patterson, M. Daly, Y. Wan, and A. Goren for helpful discussions.
References
1. Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, Kosmicki JA, 
Rehnstrom K, Mallick S, Kirby A, Wall DP, MacArthur DG, Gabriel SB, DePristo M, Purcell SM, 
Palotie A, Boerwinkle E, Buxbaum JD, Cook EH Jr, Gibbs RA, Schellenberg GD, Sutcliffe JS, 
Devlin B, Roeder K, Neale BM, Daly MJ. A framework for the interpretation of de novo mutation 
in human disease. Nat Genet. 2014; 46:944–50. [PubMed: 25086666] 
2. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional 
variation and the interpretation of personal genomes. PLoS Genet. 2013; 9:e1003709. [PubMed: 
23990802] 
3. Gulko B, Hubisz MJ, Gronau I, Siepel A. A method for calculating probabilities of fitness 
consequences for point mutations across the human genome. Nat Genet. 2015; 47:276–83. 
[PubMed: 25599402] 
4. di Iulio J, Bartha I, Wong E, Yu H-C, Hicks M, Shah N, Lavrenko V, Kirkness E, Fabani M, Yang D, 
Jung I, Biggs W, Ren B, Venter JC, Telenti A. The human functional genome defined by genetic 
diversity. 2016 bioRxiv. 
5. Willems T, Gymrek M, Highnam G, Mittelman D, Erlich Y. Genomes Project C. The landscape of 
human STR variation. Genome Res. 2014; 24:1894–904. [PubMed: 25135957] 
6. Mirkin SM. Expandable DNA repeats and human disease. Nature. 2007; 447:932–40. [PubMed: 
17581576] 
7. Houge G, Bruland O, Bjornevoll I, Hayden MR, Semaka A. De novo Huntington disease caused by 
26–44 CAG repeat expansion on a low-risk haplotype. Neurology. 2013; 81:1099–100. [PubMed: 
23946314] 
8. Amiel J, Trochet D, Clement-Ziza M, Munnich A, Lyonnet S. Polyalanine expansions in human. 
Hum Mol Genet. 2004; 13(Spec No 2):R235–43. [PubMed: 15358730] 
9. Press MO, Carlson KD, Queitsch C. The overdue promise of short tandem repeat variation for 
heritability. Trends Genet. 2014; 30:504–12. [PubMed: 25182195] 
10. Gymrek M, Willems T, Guilmatre A, Zeng H, Markus B, Georgiev S, Daly MJ, Price AL, 
Pritchard JK, Sharp AJ, Erlich Y. Abundant contribution of short tandem repeats to gene 
expression variation in humans. Nat Genet. 2016; 48:22–9. [PubMed: 26642241] 
11. Quilez J, Guilmatre A, Garg P, Highnam G, Gymrek M, Erlich Y, Joshi RS, Mittelman D, Sharp 
AJ. Polymorphic tandem repeats within gene promoters act as modifiers of gene expression and 
DNA methylation in humans. Nucleic Acids Res. 2016; 44:3750–62. [PubMed: 27060133] 
12. Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of 
microsatellite instability across 18 cancer types. Nat Med. 2016; 22:1342–1350. [PubMed: 
27694933] 
13. Ballantyne KN, Goedbloed M, Fang R, Schaap O, Lao O, Wollstein A, Choi Y, van Duijn K, 
Vermeulen M, Brauer S, Decorte R, Poetsch M, von Wurmb-Schwark N, de Knijff P, Labuda D, 
Gymrek et al. Page 14
Nat Genet. Author manuscript; available in PMC 2018 March 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Vezina H, Knoblauch H, Lessig R, Roewer L, Ploski R, Dobosz T, Henke L, Henke J, Furtado MR, 
Kayser M. Mutability of Y-chromosomal microsatellites: rates, characteristics, molecular bases, 
and forensic implications. Am J Hum Genet. 2010; 87:341–53. [PubMed: 20817138] 
14. Burgarella C, Navascues M. Mutation rate estimates for 110 Y-chromosome STRs combining 
population and father-son pair data. Eur J Hum Genet. 2011; 19:70–5. [PubMed: 20823913] 
15. Sun JX, Helgason A, Masson G, Ebenesersdottir SS, Li H, Mallick S, Gnerre S, Patterson N, Kong 
A, Reich D, Stefansson K. A direct characterization of human mutation based on microsatellites. 
Nat Genet. 2012; 44:1161–5. [PubMed: 22922873] 
16. Weber JL, Wong C. Mutation of human short tandem repeats. Hum Mol Genet. 1993; 2:1123–8. 
[PubMed: 8401493] 
17. Ellegren H. Heterogeneous mutation processes in human microsatellite DNA sequences. Nat 
Genet. 2000; 24:400–2. [PubMed: 10742106] 
18. Mallick S, Li H, Lipson M, Mathieson I, Gymrek M, Racimo F, Zhao M, Chennagiri N, Nordenfelt 
S, Tandon A, Skoglund P, Lazaridis I, Sankararaman S, Fu Q, Rohland N, Renaud G, Erlich Y, 
Willems T, Gallo C, Spence JP, Song YS, Poletti G, Balloux F, van Driem G, de Knijff P, Romero 
IG, Jha AR, Behar DM, Bravi CM, Capelli C, Hervig T, Moreno-Estrada A, Posukh OL, 
Balanovska E, Balanovsky O, Karachanak-Yankova S, Sahakyan H, Toncheva D, Yepiskoposyan 
L, Tyler-Smith C, Xue Y, Abdullah MS, Ruiz-Linares A, Beall CM, Di Rienzo A, Jeong C, 
Starikovskaya EB, Metspalu E, Parik J, Villems R, Henn BM, Hodoglugil U, Mahley R, Sajantila 
A, Stamatoyannopoulos G, Wee JT, Khusainova R, Khusnutdinova E, Litvinov S, Ayodo G, 
Comas D, Hammer MF, Kivisild T, Klitz W, Winkler CA, Labuda D, Bamshad M, Jorde LB, 
Tishkoff SA, Watkins WS, Metspalu M, Dryomov S, Sukernik R, Singh L, Thangaraj K, Paabo S, 
Kelso J, Patterson N, Reich D. The Simons Genome Diversity Project: 300 genomes from 142 
diverse populations. Nature. 2016; 538:201–206. [PubMed: 27654912] 
19. Willems T, Gymrek M, Poznik GD, Tyler-Smith C, Erlich Y. Genomes Project Chromosome YG. 
Population-Scale Sequencing Data Enable Precise Estimates of Y-STR Mutation Rates. Am J Hum 
Genet. 2016; 98:919–33. [PubMed: 27126583] 
20. Li H, Durbin R. Inference of human population history from individual whole-genome sequences. 
Nature. 2011; 475:493–6. [PubMed: 21753753] 
21. Willems T, Zielinski D, Yuan J, Gordon A, Gymrek M, Erlich Y. Genome-wide profiling of 
heritable and de novo STR variations. Nat Methods. 2017; 14:590–592. [PubMed: 28436466] 
22. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth 
GT, McVean GA. Genomes Project C. An integrated map of genetic variation from 1,092 human 
genomes. Nature. 2012; 491:56–65. [PubMed: 23128226] 
23. Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. 2013; 
1303 ArXiv e-prints. 
24. Gymrek M, Golan D, Rosset S, Erlich Y. lobSTR: A short tandem repeat profiler for personal 
genomes. Genome Res. 2012; 22:1154–62. [PubMed: 22522390] 
25. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware 
JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, 
Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, 
Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, 
Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose 
SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, 
Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, 
Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, 
McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, 
Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, 
Daly MJ, MacArthur DG. Exome Aggregation C. Analysis of protein-coding genetic variation in 
60,706 humans. Nature. 2016; 536:285–91. [PubMed: 27535533] 
26. Mastushita M, Kitoh H, Subasioglu A, Kurt Colak F, Dundar M, Mishima K, Nishida Y, Ishiguro 
N. A Glutamine Repeat Variant of the RUNX2 Gene Causes Cleidocranial Dysplasia. Mol 
Syndromol. 2015; 6:50–3. [PubMed: 25852448] 
27. Shibata A, Machida J, Yamaguchi S, Kimura M, Tatematsu T, Miyachi H, Matsushita M, Kitoh H, 
Ishiguro N, Nakayama A, Higashi Y, Shimozato K, Tokita Y. Characterisation of novel RUNX2 
Gymrek et al. Page 15
Nat Genet. Author manuscript; available in PMC 2018 March 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
mutation with alanine tract expansion from Japanese cleidocranial dysplasia patient. Mutagenesis. 
2016; 31:61–7. [PubMed: 26220009] 
28. Goodman FR, Mundlos S, Muragaki Y, Donnai D, Giovannucci-Uzielli ML, Lapi E, Majewski F, 
McGaughran J, McKeown C, Reardon W, Upton J, Winter RM, Olsen BR, Scambler PJ. 
Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc 
Natl Acad Sci U S A. 1997; 94:7458–63. [PubMed: 9207113] 
29. La Spada AR, Taylor JP. Repeat expansion disease: progress and puzzles in disease pathogenesis. 
Nat Rev Genet. 2010; 11:247–58. [PubMed: 20177426] 
30. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. 
Bioinformatics. 2010; 26:841–2. [PubMed: 20110278] 
31. Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, Jin X, Jian M, Liu G, Greer D, Bhandari A, 
Wu W, Corominas R, Peoples A, Koren A, Gore A, Kang S, Lin GN, Estabillo J, Gadomski T, 
Singh B, Zhang K, Akshoomoff N, Corsello C, McCarroll S, Iakoucheva LM, Li Y, Wang J, Sebat 
J. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell. 
2012; 151:1431–42. [PubMed: 23260136] 
32. Telenti A, Pierce LC, Biggs WH, di Iulio J, Wong EH, Fabani MM, Kirkness EF, Moustafa A, 
Shah N, Xie C, Brewerton SC, Bulsara N, Garner C, Metzker G, Sandoval E, Perkins BA, Och FJ, 
Turpaz Y, Venter JC. Deep sequencing of 10,000 human genomes. Proc Natl Acad Sci U S A. 
2016; 113:11901–11906. [PubMed: 27702888] 
33. Huang QY, Xu FH, Shen H, Deng HY, Liu YJ, Liu YZ, Li JL, Recker RR, Deng HW. Mutation 
patterns at dinucleotide microsatellite loci in humans. Am J Hum Genet. 2002; 70:625–34. 
[PubMed: 11793300] 
34. Haasl RJ, Payseur BA. Microsatellites as targets of natural selection. Mol Biol Evol. 2013; 30:285–
98. [PubMed: 23104080] 
35. Ballantyne KN, Ralf A, Aboukhalid R, Achakzai NM, Anjos MJ, Ayub Q, Balazic J, Ballantyne J, 
Ballard DJ, Berger B, Bobillo C, Bouabdellah M, Burri H, Capal T, Caratti S, Cardenas J, Cartault 
F, Carvalho EF, Carvalho M, Cheng B, Coble MD, Comas D, Corach D, D’Amato ME, Davison S, 
de Knijff P, De Ungria MC, Decorte R, Dobosz T, Dupuy BM, Elmrghni S, Gliwinski M, Gomes 
SC, Grol L, Haas C, Hanson E, Henke J, Henke L, Herrera-Rodriguez F, Hill CR, Holmlund G, 
Honda K, Immel UD, Inokuchi S, Jobling MA, Kaddura M, Kim JS, Kim SH, Kim W, King TE, 
Klausriegler E, Kling D, Kovacevic L, Kovatsi L, Krajewski P, Kravchenko S, Larmuseau MH, 
Lee EY, Lessig R, Livshits LA, Marjanovic D, Minarik M, Mizuno N, Moreira H, Morling N, 
Mukherjee M, Munier P, Nagaraju J, Neuhuber F, Nie S, Nilasitsataporn P, Nishi T, Oh HH, 
Olofsson J, Onofri V, Palo JU, Pamjav H, Parson W, Petlach M, Phillips C, Ploski R, Prasad SP, 
Primorac D, Purnomo GA, Purps J, Rangel-Villalobos H, Rebala K, Rerkamnuaychoke B, 
Gonzalez DR, Robino C, Roewer L, Rosa A, Sajantila A, Sala A, Salvador JM, Sanz P, Schmitt C, 
Sharma AK, Silva DA, Shin KJ, Sijen T, Sirker M, Sivakova D, Skaro V, Solano-Matamoros C, 
Souto L, Stenzl V, Sudoyo H, Syndercombe-Court D, Tagliabracci A, Taylor D, Tillmar A, 
Tsybovsky IS, Tyler-Smith C, van der Gaag KJ, Vanek D, Volgyi A, Ward D, Willemse P, Yap EP, 
Yong RY, Pajnic IZ, Kayser M. Toward male individualization with rapidly mutating y-
chromosomal short tandem repeats. Hum Mutat. 2014; 35:1021–32. [PubMed: 24917567] 
36. Amos W, Kosanovic D, Eriksson A. Inter-allelic interactions play a major role in microsatellite 
evolution. Proc Biol Sci. 2015; 282:20152125. [PubMed: 26511050] 
37. Garza JC, Slatkin M, Freimer NB. Microsatellite allele frequencies in humans and chimpanzees, 
with implications for constraints on allele size. Mol Biol Evol. 1995; 12:594–603. [PubMed: 
7659015] 
38. Excoffier L, Foll M. fastsimcoal: a continuous-time coalescent simulator of genomic diversity 
under arbitrarily complex evolutionary scenarios. Bioinformatics. 2011; 27:1332–4. [PubMed: 
21398675] 
39. Helgason A, Einarsson AW, Guethmundsdottir VB, Sigurethsson A, Gunnarsdottir ED, Jagadeesan 
A, Ebenesersdottir SS, Kong A, Stefansson K. The Y-chromosome point mutation rate in humans. 
Nat Genet. 2015; 47:453–7. [PubMed: 25807285] 
40. Poznik GD, Xue Y, Mendez FL, Willems TF, Massaia A, Wilson Sayres MA, Ayub Q, McCarthy 
SA, Narechania A, Kashin S, Chen Y, Banerjee R, Rodriguez-Flores JL, Cerezo M, Shao H, 
Gymrek M, Malhotra A, Louzada S, Desalle R, Ritchie GR, Cerveira E, Fitzgerald TW, Garrison 
Gymrek et al. Page 16
Nat Genet. Author manuscript; available in PMC 2018 March 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
E, Marcketta A, Mittelman D, Romanovitch M, Zhang C, Zheng-Bradley X, Abecasis GR, 
McCarroll SA, Flicek P, Underhill PA, Coin L, Zerbino DR, Yang F, Lee C, Clarke L, Auton A, 
Erlich Y, Handsaker RE, Bustamante CD, Tyler-Smith C. Genomes Project C. Punctuated bursts in 
human male demography inferred from 1,244 worldwide Y-chromosome sequences. Nat Genet. 
2016; 48:593–9. [PubMed: 27111036] 
Gymrek et al. Page 17
Nat Genet. Author manuscript; available in PMC 2018 March 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Estimating STR mutation parameters from diploid data
(a) SNPs and STRs give orthogonal molecular clocks. The tree represents an example 
evolutionary history of an STR locus. Red dots denote STR mutation events. Blue dots 
represent SNP mutation events. Black branches denote an observed diploid locus, consisting 
of two haplotypes from the tree. Bolded nucleotides represent sequence differences between 
the two haplotypes. (b) Correlating local TMRCA with STR genotypes allows per-locus 
mutation rate estimation. For each diploid STR call, we use SNP heterozygosity to 
estimate the TMRCA of the surrounding region and we compute the squared difference 
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between the two STR alleles. Our STR mutation model describes the expected ASD for a 
given TMRCA (solid black line).
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Figure 2. Accurate estimation of STR mutation parameters from simulated data
(a) Per-locus estimates of mutation rate. Dashed gray lines give boundaries enforced 
during numerical optimization. (b) Jointly estimating parameters across loci allows 
inference of low mutation rates. Black lines give joint estimates for different simulated 
mutation rates. Dashed gray lines give simulated values. (c) Y-STR mutation rate 
parameters are concordant across estimation methods. Mutation rate estimates from this 
study compared to those generated by MUTEA. Gray dashed lines denote the diagonal 
(N=41). (d) Autosomal mutation rate estimates are concordant with de novo studies. 
Histograms gives the distribution of per-locus mutation rates estimated by this study. Dashed 
lines give median estimates across loci. Solid lines give empirical mutation rates from trio 
data analyzed by Sun et al.15
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Figure 3. A framework for measuring STR constraint
(a) Schematic of constraint framework. In the model training phase, a linear model is 
trained to predict mutation rates from local sequence features. In the estimation phase, 
constraint is measured by comparing predicted mutation rates to observed rates. (b) 
Sequence features are predictive of mutation rate. Comparison of predicted vs. observed 
mutation rates for a held out test set of intergenic loci. Gray dots denote loci with high or 
undefined standard errors that were excluded from model training. (c) Enrichment of gene 
annotations by constraint bin. X-axis gives bins defined by Z-score deciles. Y-axis gives 
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the fold enrichment of each annotation in each bin. The dashed line gives the boundary 
between constrained (Z<0) and non-constrained (Z>=0) scores. (d) Predicted mutation 
rates by annotation. Center lines denote medians, boxes span the interquartile range, and 
whiskers extend beyond the box limits by 1.5 times the interquartile range. For (c) and (d), 
constrained denotes STRs in genes with missense constraint score >3 as reported by ExAC.
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Figure 4. Constraint scores can be used for STR prioritization
(a) Z-scores for example loci. Black indicates CODIS forensics markers. Blue indicates 
known pathogenic STRs. For each STR, the CODIS marker or gene name is given and the 
chromosomal location (GRCh37) is indicated in parentheses. (b) Example distributions of 
estimated vs. expected mutation rates. The left panel shows a CODIS STR (D19S433), a 
presumably neutral STR. The middle panel shows a highly constrained polyglutamine repeat 
in RUNX2 for which a mild expansion is implicated in cleidocranial dysplasia, an early 
onset disorder. The right panel shows a polyglutamine repeat in ATXN7, implicated in 
spinocerebellar ataxia type 7, a late onset disorder and accordingly not highly constrained.
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